| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0922-4106(93)90029-9 |
| P698 | PubMed publication ID | 8094338 |
| P2093 | author name string | W D Bowen | |
| B J Vilner | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 199-201 | |
| P577 | publication date | 1993-01-01 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Sigma receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture | |
| P478 | volume | 244 |
| Q24616403 | Antagonist action of progesterone at σ-receptors in the modulation of voltage-gated sodium channels |
| Q36960962 | Assessment of cellular proliferation in tumors by PET using 18F-ISO-1. |
| Q35591598 | Characterization and evaluation of two novel fluorescent sigma-2 receptor ligands as proliferation probes. |
| Q44401029 | Cytotoxicity of conventional and atypical antipsychotic drugs in relation to glucose metabolism |
| Q64963565 | Emerging therapeutic potential of anti-psychotic drugs in the management of human glioma: A comprehensive review. |
| Q40727959 | Evaluation of the neurotoxic activity of typical and atypical neuroleptics: relevance to iatrogenic extrapyramidal symptoms. |
| Q38163420 | Glioblastoma treatment using perphenazine to block the subventricular zone's tumor trophic functions |
| Q40996612 | Increased binding to sigma sites of N-[1'(2-piperidinyl)ethyl)-4-[I-125]-iodobenzamide (I-125-PAB) with onset of tumor cell proliferation |
| Q48380205 | Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: suppression of NF-kappaB and neuroprotection by antioxidants. |
| Q42743497 | New positron emission tomography (PET) radioligand for imaging σ-1 receptors in living subjects |
| Q21129360 | Novel progesterone receptors: neural localization and possible functions |
| Q37052594 | Sigma (σ) receptor ligand, AC927 (N-phenethylpiperidine oxalate), attenuates methamphetamine-induced hyperthermia and serotonin damage in mice |
| Q52757903 | Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity. |
| Q90454252 | Sigma Receptors as Endoplasmic Reticulum Stress "Gatekeepers" and their Modulators as Emerging New Weapons in the Fight Against Cancer |
| Q41153520 | Sigma binding in a human neuroblastoma cell line |
| Q28266963 | Sigma receptors: biology and therapeutic potential |
| Q33919837 | Sigma receptors: recent advances and new clinical potentials |
| Q37279268 | Sigma-2 receptor ligand as a novel method for delivering a SMAC mimetic drug for treating ovarian cancer |
| Q40913236 | Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor |
| Q36540952 | The Sigma-2 Receptor and Progesterone Receptor Membrane Component 1 are Different Binding Sites Derived From Independent Genes |
| Q36900115 | The cell death response to gamma-radiation in MCF-7 cells is enhanced by a neuroleptic drug, pimozide |
| Q33782364 | The σ2 receptor: a novel protein for the imaging and treatment of cancer |
| Q41345642 | σ Binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture |
Search more.